01349.HK
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 2.37
−0.21%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 11.59x
- P/E 2027E
- 16.40x
- P/E 2028E
- 10.30x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.97x
- Price / sales
- 3.14x
- Price / cash flow
- 12.58x
Enterprise value
- Enterprise value
- HKD 1.0B
- EV / sales
- 1.32x
- EV / EBITDA
- -15.33x
- EV / EBIT
- -6.78x
- Market cap
- HKD 2.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026